Carnegie Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.11M | Buy |
18,289
+136
| +0.7% | +$7.93K | 0.02% | 312 |
|
|
2025
Q4 | $979K | Sell |
18,153
-10,008
| -36% | -$481K | 0.02% | 327 |
|
|
2025
Q3 | $1.27M | Buy |
28,161
+330
| +1% | +$15.4K | 0.02% | 291 |
|
|
2025
Q2 | $1.29M | Sell |
27,831
-5,429
| -16% | -$266K | 0.03% | 283 |
|
|
2025
Q1 | $1.85M | Sell |
33,260
-175
| -0.5% | -$10.2K | 0.04% | 230 |
|
|
2024
Q4 | $1.89M | Buy |
33,435
+1,193
| +4% | +$66.7K | 0.05% | 213 |
|
|
2024
Q3 | $1.67M | Sell |
32,242
-1,297
| -4% | -$60.8K | 0.05% | 234 |
|
|
2024
Q2 | $1.39M | Sell |
33,539
-18,907
| -36% | -$846K | 0.04% | 238 |
|
|
2024
Q1 | $2.84M | Sell |
52,446
-25,730
| -33% | -$1.31M | 0.09% | 181 |
|
|
2023
Q4 | $4.01M | Sell |
78,176
-17,309
| -18% | -$909K | 0.14% | 152 |
|
|
2023
Q3 | $5.54M | Sell |
95,485
-2,364
| -2% | -$145K | 0.21% | 117 |
|
|
2023
Q2 | $6.26M | Sell |
97,849
-21,956
| -18% | -$1.47M | 0.23% | 110 |
|
|
2023
Q1 | $8.3M | Buy |
119,805
+10,255
| +9% | +$723K | 0.33% | 86 |
|
|
2022
Q4 | $7.88M | Buy |
109,550
+187
| +0.2% | +$14.1K | 0.34% | 85 |
|
|
2022
Q3 | $7.78M | Buy |
109,363
+16,477
| +18% | +$1.2M | 0.37% | 80 |
|
|
2022
Q2 | $7.15M | Sell |
92,886
-4,293
| -4% | -$327K | 0.32% | 88 |
|
|
2022
Q1 | $7.1M | Sell |
97,179
-381
| -0.4% | -$25.6K | 0.26% | 106 |
|
|
2021
Q4 | $6.08M | Sell |
97,560
-5,703
| -6% | -$335K | 0.2% | 128 |
|
|
2021
Q3 | $6.11M | Buy |
103,263
+12,777
| +14% | +$841K | 0.23% | 115 |
|
|
2021
Q2 | $6.05M | Buy |
90,486
+17,241
| +24% | +$1.12M | 0.23% | 116 |
|
|
2021
Q1 | $4.63M | Buy |
73,245
+11,090
| +18% | +$690K | 0.19% | 126 |
|
|
2020
Q4 | $3.85M | Sell |
62,155
-1,067
| -2% | -$65.6K | 0.17% | 136 |
|
|
2020
Q3 | $3.81M | Sell |
63,222
-2,647
| -4% | -$159K | 0.19% | 124 |
|
|
2020
Q2 | $3.87M | Buy |
65,869
+72
| +0.1% | +$4.31K | 0.22% | 114 |
|
|
2020
Q1 | $3.65M | Sell |
65,797
-2,713
| -4% | -$166K | 0.25% | 110 |
|
|
2019
Q4 | $4.4M | Buy |
68,510
+1,680
| +3% | +$96.2K | 0.25% | 110 |
|
|
2019
Q3 | $3.39M | Sell |
66,830
-264
| -0.4% | -$12.4K | 0.22% | 122 |
|
|
2019
Q2 | $3.04M | Sell |
67,094
-17,250
| -20% | -$804K | 0.2% | 126 |
|
|
2019
Q1 | $4.02M | Buy |
84,344
+3,973
| +5% | +$198K | 0.28% | 105 |
|
|
2018
Q4 | $4.18M | Sell |
80,371
-65,204
| -45% | -$3.5M | 0.39% | 79 |
|
|
2018
Q3 | $7.88M | Buy |
145,575
+22,461
| +18% | +$1.33M | 0.65% | 39 |
|
|
2018
Q2 | $7.38M | Buy |
123,114
+20,400
| +20% | +$1.1M | 0.56% | 54 |
|
|
2018
Q1 | $5.33M | Buy |
102,714
+7,686
| +8% | +$494K | 0.45% | 70 |
|
|
2017
Q4 | $5.94M | Buy |
95,028
+10,744
| +13% | +$672K | 0.53% | 54 |
|
|
2017
Q3 | $5.38M | Buy |
84,284
+33,110
| +65% | +$1.93M | 0.63% | 44 |
|
|
2017
Q2 | $2.84M | Buy |
51,174
+10,127
| +25% | +$551K | 0.35% | 85 |
|
|
2017
Q1 | $2.26M | Sell |
41,047
-177
| -0.4% | -$9.71K | 0.28% | 102 |
|
|
2016
Q4 | $2.46M | Buy |
41,224
+1,834
| +5% | +$100K | 0.33% | 87 |
|
|
2016
Q3 | $1.95M | Sell |
39,390
-796
| -2% | -$51.1K | 0.28% | 101 |
|
|
2016
Q2 | $3.06M | Buy |
40,186
+2,899
| +8% | +$205K | 0.43% | 73 |
|
|
2016
Q1 | $2.38M | Buy |
37,287
+349
| +0.9% | +$22K | 0.36% | 81 |
|
|
2015
Q4 | $2.3M | Buy |
36,938
+5,850
| +19% | +$387K | 0.4% | 73 |
|
|
2015
Q3 | $2.06M | Sell |
31,088
-1,036
| -3% | -$65.7K | 0.35% | 79 |
|
|
2015
Q2 | $2.14M | Sell |
32,124
-833
| -3% | -$54.9K | 0.37% | 86 |
|
|
2015
Q1 | $2.11M | Sell |
32,957
-2,010
| -6% | -$126K | 0.36% | 85 |
|
|
2014
Q4 | $2.12M | Buy |
34,967
+75
| +0.2% | +$4.23K | 0.4% | 83 |
|
|
2014
Q3 | $1.79M | Buy |
34,892
+13,817
| +66% | +$690K | 0.36% | 83 |
|
|
2014
Q2 | $1.02M | Buy |
21,075
+4,480
| +27% | +$221K | 0.23% | 102 |
|
|
2014
Q1 | $862K | Hold |
16,595
| – | – | 0.23% | 103 |
|
|
2013
Q4 | $882K | Sell |
16,595
-2
| -0% | -$102 | 0.24% | 103 |
|
|
2013
Q3 | $768K | Sell |
16,597
-4,925
| -23% | -$216K | 0.24% | 104 |
|
|
2013
Q2 | $962K | Buy |
+21,522
| New | +$934K | 0.32% | 90 |
|
Other funds holding BMY
VCM
VPM
Carnegie Investment Counsel's BMY Position: Q1 2026 in Review
Carnegie Investment Counsel increased its Bristol-Myers Squibb (BMY) stake by 0.75% in Q1 2026, buying an estimated $7.93K and bringing the position to 18,289 shares worth $1.11M. The position accounts for 0.02% of the portfolio, ranked #312.
Carnegie Investment Counsel first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.3M in Q1 2023. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Carnegie Investment Counsel held 18,289 shares of Bristol-Myers Squibb worth $1.11M as of Q1 2026.
- Carnegie Investment Counsel bought 136 Bristol-Myers Squibb shares in Q1 2026, an estimated $7.93K.
- Bristol-Myers Squibb made up 0.02% of Carnegie Investment Counsel's portfolio in Q1 2026, its #312 holding.
- Carnegie Investment Counsel first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Carnegie Investment Counsel's Bristol-Myers Squibb position peaked at $8.3M in Q1 2023.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Carnegie Investment Counsel's 13F filing for Q1 2026, filed 1 May 2026.